Trial intelligence / Profile preview

Intravenous Lidocaine for Rebound Pain after Spinal Anesthesia in Hemorrhoidectomy

ChiCTR2400089141Phase 4Not yet recruiting

Sponsor
Ningbo Medical Centre Lihuili Hospital
Start
Sep 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in postoperative pain comparing Lidocaine group with Placebo group (2 arms). Primary endpoint: Incidence of rebound pain. Planned start Sep 2024; status: not yet recruiting.

02

Drugs

lidocaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on ChiCTR2400089141.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2400089141.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call